SEP 07, 2017 9:00 AM PDT

WEBINAR: Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

Sponsored by: Essen BioScience
Speaker
  • Instructor, Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, USA
    BIOGRAPHY

Abstract

DATE: September 7, 2017
TIME: 9:00AM PT, 12:00PM ET

The success of immune checkpoint blockade adds a new therapeutic category to the cancer therapy repertoire. Despite efforts made on cancer cell and immune cell interaction, how cancer cells initiate immune escape is less understood. Here we reveal PD-L1’s immunosuppression activity is stringently modulated by the spatial restraints between ubiquitination and N-linked glycosylation. We identified GSK3beta as a novel PD-L1 interacting protein capable of inducing phosphorylation dependent proteasome degradation. The essence of PD-L1 N192, N200 and N219 glycosylation suggests it antagonizes GSK3beta binding. In this regard, only non-glycosylated PD-L1 forms a complex with GSK3beta and beta-TrCP. More importantly, activation of GSK3beta-mediated PD-L1 degradation by TKI can reduce membrane PD-L1 expression and thereby enhance anti-tumor immunity. To test T cell-mediated cancer cell killing in vitro, we employed a time lapse microscopy, IncuCyte, to monitor RFP-tagged BT549 cells and activated PBMC interaction over a five day period. Massive cancer cell death was observed in glycosylation deficient cancer cells, suggesting glycosylation of PD-L1 is required for its immunosuppression. Together, our results link ubiquitination and glycosylation pathways with stringent regulation of PD-L1, proposing a new therapeutic strategy to enhance cancer immune therapy efficacy.

Learning Objectives:

  • Molecular mechanism of PD-L1 regulation in cancer cells
  • Immunosuppressive nature of triple negative breast cancer 
  • Using in vitro co-culture system to analyze T cell-mediated cancer cell killing effect

 


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
SEP 07, 2017 9:00 AM PDT

WEBINAR: Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

Sponsored by: Essen BioScience

Specialty

Cancer Research

Immunology

Molecular Biology

Cell Biology

Biotechnology

Cancer Therapeutics

Biomarkers

Biochemistry

Cancer Diagnostics

Cell Culture

Molecular Diagnostics

Clinical Diagnostics

Gene Expression

Laboratory Testing

Genetics

Geography

North America64%

Europe15%

Asia13%

South America4%

Africa2%

Registration Source

Website Visitors100%

Job Title

Research Scientist18%

Student17%

Educator/Faculty13%

Scientist12%

Post Doc10%

Executive8%

Medical Laboratory Technician7%

Facility/Department Manager5%

Lab Management4%

Medical Doctor/Specialist4%

Clinical Laboratory Scientist3%

Organization

Academic Institution15%

Biotech Company5%

Hospital4%

Clinical Laboratory4%

Research Institute3%

Medical School3%

Government3%

Medical Center2%

Pharmaceutical Company1%

Consultant1%

Life Science Company1%

Industrial Company1%

Medical Device Company1%

Independent Laboratories1%

Other4%


Show Resources
Loading Comments...
Show Resources